Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 June 2021 | Story Dr Nitha Ramnath

A passion for evidence-based medicine and the notion of value in healthcare is what drives Dr Anchen Laubscher, our guest in the fifth episode of the Voices from the Free State podcast. Anchen is driven to ensure that healthcare is scientifically proven, of high quality, cost effective, and tailored to a patient’s needs.  

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them.

 

 

Google Podcasts BadgeRSS Podcasts Logo

 

Our podcast guest

Anchen joined Netcare in 2007 as an aeromedical doctor and has been with the group for almost 14 years. As Group Medical Director of Netcare Ltd, Anchen is responsible for the strategic oversight and operational execution of all clinical and quality-related matters across the different divisions of Netcare. Leading a team of subject matter experts, Anchen oversees the group’s key deliverables related to the value of care, encompassing quality outcomes, patient safety, patient experience, and episode cost efficiency, with all components of ‘value’ digitally enabled and data driven.

Anchen is a member of the Hospital Association of South Africa (HASA) subcommittee for Clinical Quality and the South African Committee of Medical Deans (SACOMD) initiative, which was constituted to address the human resource dilemma specifically related to the training of doctors in South Africa. She is a Council member of the University of the Free State, where she also serves on the Senate and holds director appointments in the Mother and Child Academic Hospital (MACAH) Foundation, the My Walk My Soul collaboration between Netcare and Adcock-Ingram and the University of Cape Town Medical Centre Ltd.  Anchen played a pioneering leadership role in South Africa’s response to the 2014 global Ebola Virus Disease (EVD) outbreak, which continues in her role as Gold Command in Netcare and as member of various national committee and advisory structures related to the COVID-19 pandemic preparedness and response. For her role in the South African EVD response, she was recognised with an honorary award from the South African Military Health Services (SAMHS).

Clinically, Anchen continues to contribute to the specialty of emergency medicine, specifically pre-hospital and aeromedicine. She continues to be involved at her alma mater through ad hoc lecturing in electives, research support at GIBS, and participating in health-care courses and conferences such as the 2020 Healthcare Industry Update and Innovation Conference.

Stay tuned for episode six to be released on 5 July 2021.

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za

Listen to all the Voices from the Free State podcasts.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept